ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2,1,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
3,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
4,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
5,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
7,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
9,1,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
9,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
9,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
10,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
11,1,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,Y
11,2,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
12,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
12,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
12,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
14,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
15,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
16,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
16,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
17,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
19,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
21,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
23,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
24,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
24,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
24,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
25,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
25,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
26,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,1,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
27,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
27,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
28,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
33,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
33,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
36,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
36,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
36,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
39,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,Y
40,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
40,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
41,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
42,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
44,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
46,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
48,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Headache,Headaches NEC,Headaches,Nerv,N
51,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
52,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
52,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
54,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
56,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
57,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
58,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
59,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
60,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
61,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
61,3,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
61,4,Urinary tract malformation,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
62,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
63,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
64,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
65,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
65,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
66,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
67,1,Schizophreniform disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
68,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
69,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
69,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
70,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
71,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
72,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
73,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
73,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
75,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
75,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
75,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
75,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
76,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
77,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
78,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
79,1,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
79,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
80,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
84,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
84,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
85,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
86,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
87,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
88,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
89,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
90,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
92,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
93,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
94,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
95,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
96,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
98,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
98,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
98,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
98,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
99,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
100,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
101,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
102,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
102,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
103,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
103,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
105,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
106,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
107,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
108,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
109,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
109,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
110,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
111,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
111,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
112,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
113,2,Headache,Headaches NEC,Headaches,Nerv,N
113,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
114,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
114,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
116,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
116,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
116,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
117,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
118,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
120,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
121,1,Myopathy,Myopathies,Muscle disorders,Musc,N
121,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
122,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
122,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
124,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
124,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
124,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
124,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
125,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
125,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
126,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
127,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
128,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
128,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
130,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
131,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
132,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
132,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
133,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
134,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
134,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
135,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
136,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
138,2,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
138,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
138,4,Testicular disorder,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
139,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
140,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
140,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
140,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
140,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
141,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
142,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
144,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
145,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
146,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
147,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
148,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
148,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
148,3,Headache,Headaches NEC,Headaches,Nerv,N
149,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
150,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
152,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
152,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
152,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
152,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
153,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
153,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
153,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
153,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
154,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
155,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
157,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
157,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
158,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
158,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
159,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
160,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
160,2,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
160,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
161,1,Infusion site phlebitis,Infusion site reactions,Administration site reactions,Genrl,N
162,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
163,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
163,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
164,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
164,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
164,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
164,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
164,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
165,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
165,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
165,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
165,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
166,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
168,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
169,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
170,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
171,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
172,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
172,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
172,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
172,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
173,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
174,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
175,1,Obstetrical pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
175,2,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
175,3,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
175,4,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
176,1,Foetal acidosis,Foetal complications NEC,Foetal complications,Preg,N
177,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
177,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
177,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
177,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
177,5,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
177,6,Uterine contractions during pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
178,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
178,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
178,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
179,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
179,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
179,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
179,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
180,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
180,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
180,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
180,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
180,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
180,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
181,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
181,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
181,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
181,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
182,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
182,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
183,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
183,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
183,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
183,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
184,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
184,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
185,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
186,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
187,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
187,2,False labour,Failed labour,Maternal complications of labour and delivery,Preg,N
187,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
187,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
188,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
188,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
189,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
190,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
191,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
192,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
192,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
192,3,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
193,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
194,1,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
195,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
196,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
196,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
197,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
197,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
197,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
197,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
197,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
198,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
198,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
198,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
198,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
199,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
200,1,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
201,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
201,2,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
201,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
201,4,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
202,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
203,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
203,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
204,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
205,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
206,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
206,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
206,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
207,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
207,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
207,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
207,4,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
207,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
208,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
208,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
209,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
210,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
210,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
210,4,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
211,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
211,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
211,3,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
211,4,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
211,5,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
211,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,7,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
211,8,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
211,9,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
211,10,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
211,11,Neonatal disorder,Newborn complications NEC,Neonatal and perinatal conditions,Preg,N
211,12,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
211,13,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
211,14,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
212,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
212,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
212,3,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
212,4,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
212,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
212,6,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
212,7,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
212,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
212,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
212,10,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
212,11,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
213,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
215,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
215,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
215,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
215,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
215,5,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
215,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
216,1,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
216,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
218,1,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
218,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
218,3,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
219,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
219,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
219,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
219,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
219,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
219,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,9,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
219,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
219,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
219,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
220,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
221,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
222,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
222,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
223,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
224,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
224,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
225,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
226,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
226,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
227,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
227,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
228,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
229,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
230,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
230,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
230,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
230,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
231,1,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
232,1,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
232,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
233,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
234,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
235,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
237,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
241,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
241,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
242,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
244,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
244,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
244,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
244,6,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
244,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
244,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
245,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
245,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
246,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
247,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
248,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
249,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
250,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
251,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
252,1,Post procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
253,1,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
254,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
254,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
255,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
255,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
255,3,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
255,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
255,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
255,7,Educational problem,Educational issues,Lifestyle issues,SocCi,N
255,8,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
255,9,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
255,10,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
255,11,Job dissatisfaction,Employment issues,Economic and housing issues,SocCi,N
255,12,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
255,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
255,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
255,15,Psychomotor skills impaired,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
256,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
258,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
258,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
258,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
258,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
258,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
258,8,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
258,9,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
258,10,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
258,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
258,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
258,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
258,15,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
258,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,17,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
258,18,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
260,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
260,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
261,1,Headache,Headaches NEC,Headaches,Nerv,N
261,2,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
262,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
262,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
262,3,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
262,4,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
262,5,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
263,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
264,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
264,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
264,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
264,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
264,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
267,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
267,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
267,5,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
267,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
267,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
268,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
269,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
271,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
272,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
273,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
273,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
274,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
274,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
274,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
274,4,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
275,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
276,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
277,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
279,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
280,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
280,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
281,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
281,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
281,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
281,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
283,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
284,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
284,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
284,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
285,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
287,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
287,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
288,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
288,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
288,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
288,7,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
289,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
290,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
291,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
292,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
294,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
297,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
299,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
300,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
301,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
302,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
303,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
303,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
304,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
304,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
304,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
305,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
308,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Multiple drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
